Psychemedics Corporation (NASDAQ:PMD)
Industry: Healthcare

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Its tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period-of-time. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. It provides its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations, as well as school and government entities. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.

Current Quote*
Last: $9.081
Change: 0.040
Book: $2.756
Volume: 2,204

As Of: 12/12 12:16 ET
*Quotes delayed by 20min.

Graphs for PMD


3 Month Graph


6 Month Graph


1 Year Graph